A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

SI-B001

Administration by intravenous infusion

DRUG

SI-B003

Administration by intravenous infusion

Trial Locations (1)

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY